Attachment 2: NCI Task Force for Drug Accountability Procedure
Investigator: Stephen Schimpff, M.D. Pharmacist: Mr. William Grove University of Maryland Cancer Center 22 S. Greene Street Baltimore, Maryland 21201 (410) 328‑7606
|
Investigator: Joseph Simone, M.D. Pharmacist: Mr. Raymond Mueller Memorial Sloan‑Kettering Cancer Center 1275 New York Ave New York, NY 10021 (212) 639‑5842 |
Investigator: Robert Warren, M.D. Nurse: Ms. Faith Jodoin 5226 Dawes Avenue Alexandria, Virginia 22311 (703) 379‑9111 |
Investigator: Ray Warrell, M.D. Pharmacist: Mr. Raymond Mueller Memorial Sloan‑Kettering Cancer Center 1275 York Avenue New York, New York 10021 (212) 794‑7615
|
Investigator: James Holland, M.D. Pharmacist: Mr. Robert Frank Mt. Sinai Hospital 1 Gustave L. Levy Place New York, New York 10029 (212) 41‑6361
|
Investigator: Philip Schein, M.D. U.S. Bioscience, Inc. One Tower Bridge, Ste 400 West Conshohockem, PA 19428 (215) 832‑4501 |
Investigator: Emil Frei, M.D. Pharmacist: Dr. Steve Steckel Dana Farber Cancer Center 44 Binney Street Boston, Massachusetts 02115 (617) 632‑3555
|
|
| File Type | application/msword |
| Author | Vivian Horovitch-Kelley |
| Last Modified By | Vivian Horovitch-Kelley |
| File Modified | 2010-07-09 |
| File Created | 2010-07-07 |